140 related articles for article (PubMed ID: 36575788)
1. [SENP1 induced protein deSUMO modification increased the chemotherapy sensitivity of endometrial cancer side population cells].
Yuan ML; Bai J; Li CY; Xue N; Chen XH; Sheng F; Liu XZ; Li P
Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1362-1368. PubMed ID: 36575788
[No Abstract] [Full Text] [Related]
2. [Hypoxia inducible factor-1α deSUMOylation reduces the stemness maintenance ability of endometrial cancer stem cell and increases its chemosensitivity].
Yuan L; Jiang ZM; Chen XH; Bian XY; Li YX; Ma XF; Liu XZ
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3579-3582. PubMed ID: 29275599
[No Abstract] [Full Text] [Related]
3. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract][Full Text] [Related]
4. miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling.
Dai J; Hao Y; Chen X; Yu Q; Wang B
Oncol Lett; 2023 Sep; 26(3):390. PubMed ID: 37559577
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.
Zhao N; Guo Y; Liu P; Chen Y; Wang Y
Arch Gynecol Obstet; 2022 Mar; 305(3):693-701. PubMed ID: 34476599
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV.
Liu F; Li L; Li Y; Ma X; Bian X; Liu X; Wang G; Zhang D
Int J Oncol; 2018 Nov; 53(5):2010-2020. PubMed ID: 30226577
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.
Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051
[TBL] [Abstract][Full Text] [Related]
8. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
[TBL] [Abstract][Full Text] [Related]
9. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
Witty J; Aguilar-Martinez E; Sharrocks AD
Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
[TBL] [Abstract][Full Text] [Related]
10. Effect of shRNA-mediated regulation of S100A4 gene expression on proliferation and apoptosis of KLE endometrial cancer cells.
Ren W; Chi YB; Sun JL
Clin Transl Oncol; 2021 Jan; 23(1):148-154. PubMed ID: 32472453
[TBL] [Abstract][Full Text] [Related]
11. [Ribosomal Protein S9 Expression in Multiple Myeloma and Its Effect on Cell Biological Function].
Song KP; Shu P; Ma JL; Wang B; Chen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):175-182. PubMed ID: 31060671
[TBL] [Abstract][Full Text] [Related]
12. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
13. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
[TBL] [Abstract][Full Text] [Related]
14. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
15. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
[TBL] [Abstract][Full Text] [Related]
16. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines.
Gao Y; Liu T; Cheng W; Wang H
Oncol Rep; 2012 Aug; 28(2):527-32. PubMed ID: 22581025
[TBL] [Abstract][Full Text] [Related]
18. Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
Wei J; Wang H; Zheng Q; Zhang J; Chen Z; Wang J; Ouyang L; Wang Y
Eur J Med Chem; 2022 Nov; 241():114650. PubMed ID: 35939992
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of leukemia inhibitory factor enhances chemotherapy tolerance of endometrial cancer cells
Ruan X; Zhong M; Liu W; Liu Q; Lu W; Zheng Y; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):20-26. PubMed ID: 32376564
[TBL] [Abstract][Full Text] [Related]
20. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
